Literature DB >> 27239259

Host factors are dominant in the development of post-liver transplant non-alcoholic steatohepatitis.

Salih Boga1, Armando Salim Munoz-Abraham1, Manuel I Rodriguez-Davalos1, Sukru H Emre1, Dhanpat Jain1, Michael L Schilsky1.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a recognized problem in patients after orthotopic liver transplantation and may lead to recurrent graft injury. As the increased demand for liver allografts fail to match the available supply of donor organs, split liver transplantation (SLT) has emerged as an important technique to increase the supply of liver grafts. SLT allows two transplants to occur from one donor organ, and provides a unique model for observing the pathogenesis of NAFLD with respect to the role of recipient environmental and genetic factors. Here we report on two recipients of a SLT from the same deceased donor where only one developed non-alcoholic steatohepatitis (NASH), suggesting that host factors are critical for the development of NASH.

Entities:  

Keywords:  Host factors; Liver; Split graft; Steatohepatitis; Transplant

Year:  2016        PMID: 27239259      PMCID: PMC4876289          DOI: 10.4254/wjh.v8.i15.659

Source DB:  PubMed          Journal:  World J Hepatol


  20 in total

1.  Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

Authors:  Elisabetta Bugianesi; Nicola Leone; Ester Vanni; Giulio Marchesini; Franco Brunello; Patrizia Carucci; Alessandro Musso; Paolo De Paolis; Lorenzo Capussotti; Mauro Salizzoni; Mario Rizzetto
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

Review 2.  Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment.

Authors:  Sandra Milić; Davor Stimac
Journal:  Dig Dis       Date:  2012-06-20       Impact factor: 2.404

3.  Hyperlipidemia in liver transplant recipients: prevalence and risk factors.

Authors:  C Gisbert; M Prieto; M Berenguer; M Bretó; D Carrasco; M de Juan; J Mir; J Berenguer
Journal:  Liver Transpl Surg       Date:  1997-07

Review 4.  Split-liver transplantation. The Paul Brousse policy.

Authors:  D Azoulay; I Astarcioglu; H Bismuth; D Castaing; P Majno; R Adam; M Johann
Journal:  Ann Surg       Date:  1996-12       Impact factor: 12.969

5.  Hyperlipidemia after liver transplantation: natural history and treatment with the hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin.

Authors:  D K Imagawa; S Dawson; C D Holt; P S Kirk; F M Kaldas; C R Shackleton; P Seu; S M Rudich; M M Kinkhabwala; P Martin; L I Goldstein; N G Murray; P I Terasaki; R W Busuttil
Journal:  Transplantation       Date:  1996-10-15       Impact factor: 4.939

6.  Excessive weight gain after liver transplantation.

Authors:  M Palmer; F Schaffner; S N Thung
Journal:  Transplantation       Date:  1991-04       Impact factor: 4.939

Review 7.  Hepatic iron overload following liver transplantation of a C282y homozygous allograft: a case report and literature review.

Authors:  Jeremy P Dwyer; Shahzad Sarwar; Brian Egan; Niamh Nolan; John Hegarty
Journal:  Liver Int       Date:  2011-07-29       Impact factor: 5.828

8.  Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.

Authors:  Hyeyoung Kim; Kyoungbun Lee; Kwang-Woong Lee; Nam-Joon Yi; Hae Won Lee; Geun Hong; YoungRok Choi; Tae You; Suk-Won Suh; Ja June Jang; Kyung-Suk Suh
Journal:  Clin Transplant       Date:  2014-04-16       Impact factor: 2.863

9.  Weight change and obesity after liver transplantation: incidence and risk factors.

Authors:  J E Everhart; M Lombardero; J R Lake; R H Wiesner; R K Zetterman; J H Hoofnagle
Journal:  Liver Transpl Surg       Date:  1998-07

10.  Prevalence and risk factors of steatosis after liver transplantation and patient outcomes.

Authors:  Irena Hejlova; Eva Honsova; Eva Sticova; Vera Lanska; Tomas Hucl; Julius Spicak; Milan Jirsa; Pavel Trunecka
Journal:  Liver Transpl       Date:  2016-04-05       Impact factor: 5.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.